Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon
I Can Extract Side Effects
Chapter 164

Let's start with the world's most expensive drug.

1,998 words 7 min read 3 views 4mo ago Source ​
Skip to the end of the chapter
Prev
Next

Gene Therapy, a term often found in science fiction, is now entering people's lives.

A global Gene Therapy craze is sweeping the world, with Gene Therapy drugs emerging one after another overseas.

Unfortunately, although China's Gene Therapy drugs took the lead back then, they remained dormant for a full twenty years due to internal reasons and are still absent from this crucial medical battlefield.

The idea of Gene Therapy actually emerged quite early, as early as 1972. The idea at that time was to insert healthy genes into cells to replace disease-causing gene variants through DNA-based drugs.

The idea was wonderful, but realizing it was extremely difficult. It involved decades of failed experiments, route exploration, and even the deaths of some patients. The journey was full of hardships.

The world's first Gene Therapy drug, "Jin Yousheng," was actually launched in China in 2003. It was an anti-tumor Gene Therapy drug, which was groundbreaking at the time.

However, due to a lack of funding for subsequent clinical development and the introduction of investors, the company became embroiled in Patent Dispute between scientists and entrepreneurs. This prolonged internal conflict completely destroyed the first drug to be developed, and it is now a thing of the past.

In 2014, the second Gene Therapy drug was first launched in Europa for the treatment of Lipoprotein Lipase Deficiency, a rare genetic disease. However, due to the small number of patients with the disease (an incidence rate of only one in a million) and the high price of $1 million, only one case was sold after its launch, and it was withdrawn from the market four years later.

In 2017, the first in vivo Gene Therapy drug in the Eagle Country received FDA approval, marking the official arrival of the Gene Therapy era.

Following this, the pace of bringing Gene Therapy drugs to market accelerated rapidly.

Gene Therapy encompasses cell therapy, Gene Therapy, and nucleic acid therapy. Currently, more than 20 Gene Drug are available worldwide for the treatment of Cancer, viral infections, and hereditary diseases.

After nearly half a century, Gene Therapy has gone from concept to reality.

According to forecasts, the global market size for Gene Therapy will grow 44 times from $1 billion in 2017 to $44 billion in just a few years.

Gene Therapy has been, and will continue to be, one of the most watched areas in the pharmaceutical industry in the past and for years to come.

Countless patients will benefit from this, and in the face of such a grand occasion, people can even let their imaginations run wild and envision the real future.

That future, which only exists in science fiction novels, may be gradually being replicated in reality, and is speeding towards a direction that people cannot imagine.

"Clap clap clap," a round of enthusiastic applause rang out.

One by one, the employees stood up from their seats and clapped excitedly.

They were all deeply moved when they saw the Genomics achievements made by foreign research teams, and they wished they could make such achievements themselves.

What is the biggest dream in the heart of every biology student?

Isn't it all about unlocking the genetic code, unraveling the mysteries of life, and thus reshaping the fate of humanity?

And now, the whole world has taken a solid step toward this goal.

They, too, will ride the wind, catch up with this wave, and soar and dance on the cusp of opportunity.

A sea of expectant eyes turned to Tang Que.

He stood in the center, holding a model of a DNA double helix structure.

Amid the applause, he had calmed down and looked at the crowd surrounding him.

"Alright, I've declared war. What are your thoughts and questions?"

The employees looked at each other, bewildered.

They had been working under Tang Que for a while, but sometimes they still couldn't keep up with their leader's unpredictable and often erratic thinking.

While this declaration sounds inspiring, could you please provide some details? Also, it seems that they can't decide exactly which direction to focus their efforts on.

A well-mannered young man raised his hand. "Dr. Tang, I have a few questions. Do we already have a target? Which Rare Disease should we start with?"

"Should we have a standard for selecting target diseases, such as starting with Rare Disease that have the most patients, or from other aspects?"

"The generic drug division is developing drugs for many Rare Disease. Should we communicate with them more?"

Tang Que looked at him with admiration and nodded. "Jiang Kai, the question you raised is very good. It proves that you have your own thoughts, which is very rare. I admire you."

He raised a finger and said slowly, "I have already chosen my target."

"As for the selection criteria, it's very simple. We'll first learn from our competitors, imitate their treatment pathways and drug delivery routes, and then make improvements. Once everyone is familiar with the process and can get ashore, then we can start running freely."

"There are about 20 Gene Therapy drugs on the market now. We will start with the most mature and most expensive ones."

"The generic drug sector doesn't involve much technology; they're all working on small molecule drugs, which is different from the biological macromolecule drugs we're researching. The directions are completely different. They treat the symptoms, while we treat the root cause."

"You can communicate with them about other aspects besides research and development."

"Alright, now everyone should understand."

"I have another question to ask you all," Tang Que said, raising his finger in front of him and scanning the entire room with his sharp eyes.

"Can anyone tell me what the most expensive drug in the world is today?"

The scene fell silent instantly.

After a few seconds, a short man wearing glasses looked around and timidly raised his hand. "I, I know."

Tang Que shook his head in disappointment, his voice unusually cold. "I asked a question, so if you know the answer, just say it."

He suddenly shouted, "When you do business with me, you have to be direct, understand?"

A few scattered voices rang out. "Understood."

Tang Que glared at him. "Bullshit, your voice is so soft. I can't hear you!"

The entire audience instantly shouted, "I understand!"

The short, bespectacled man puffed out his chest and shouted, "We understand!"

Tang Que clapped loudly. "Good, that's more like it, that's more like it's manly, that's more like it's crazy."

"Now tell me, what is the most expensive drug in the world?"

He asked again, this time with all his might, the deafening sound sweeping across the scene like a gust of wind.

Everyone stood tall and proud, shouting, "Zolgensma!"

"Which company? What illness does it treat?"

"Novartis, Spinal Muscular Atrophy (SMA)".

Everyone's lungs were pumping like bellows, loudly exhaling these names.

After he finished speaking, they stared at Tang Que, waiting for him to continue.

Tang Que put his hand to his ear, fanned himself, and asked, "What's the price? I didn't hear the price."

The short, bespectacled man was the first to blurt out the words, which came out of his mouth like machine gun fire.

"The price is as high as $2.1 million, which is about 14 million yuan."

Tang Que looked at him this time and nodded. "Very good, you've improved. Next time, just say the answer directly and don't waste any breath."

The short, bespectacled man nervously swallowed, nodded, and kept his lips tightly closed, saying nothing more.

The DNA molecule model in Tang Que's hand kept spinning and jumping as he continued to talk non-stop.

"Spinal Muscular Atrophy (SMA) is a very rare neuromuscular genetic disease, affecting only tens of thousands of people worldwide. The treatment developed by Novartis uses adeno-associated virus (AAV) to deliver the correct human SMN1 gene into the patient's cells, thereby restoring the patient's motor function."

"This is a real Gene Therapy drug; just one injection can completely cure the patient."

"This drug is not currently available in China, but it has already obtained a clinical trial application from the Drug Administration Bureau."

"Because it is so effective, its market sales are growing steadily, reaching $1.3 billion last year."

"However, this is not the only drug for treating SMA. There are three SMA treatment drugs on the market globally, and the other two have already been launched in China."

"The price is also very high, but it's a bit cheaper than Novartis's."

"Many people may still remember the incident last year where a single injection of a drug cost 700,000 yuan. That drug was Biogen's antisense oligonucleotide drug Spiraza, used to treat SMA."

"It has been on the market in China for more than two years. Patients need to take the medication for life through lumbar puncture. Previously, the price was too high and sales were not good. Later, after negotiations, it was included in the medical insurance catalog, and the price of 700,000 yuan per injection was reduced to 30,000 yuan per injection. In this way, the treatment cost for patients in the first year is about 100,000 yuan, and they will need 50,000 yuan every year thereafter. After reimbursement, it should be even lower."

"The last one is Roche's Evrysdi, which is an oral medication and is also very expensive. It is priced at 60,000 yuan per bottle in China and is not yet covered by medical insurance. The annual treatment cost for a child is about 400,000 to 500,000 yuan."

Tang Que's expression suddenly turned serious, and he stopped playing with the model in his hand. "What I, Tang Que, can't stand the most is exorbitantly priced drugs. Biogen can lower its prices, so why can't Roche and Huawei lower their prices?"

"The price is outrageously high, 14 million per injection. It's just outrageous beyond belief, outrageous to the extreme."

"Isn't there a monopoly involved? Pharmaceutical companies need profits, but this shouldn't be so outrageous."

"Out of 10,000 patients worldwide, how many can afford this price? Are those who can't afford it just supposed to watch themselves die?"

Tang Que shook his head and took a deep breath. "The development of technology should make everyone better and better, not make us suffer and die while looking at the technological products in front of us."

"The more mature the technology, the more we can drive down the cost. Now, let's become cost killers. China manufacturing has always had this glorious tradition."

"Our goal is to develop our own SMA Gene Therapy Drug, bring these exorbitantly priced drugs down from their high prices, restore their value, and let them return to the essence of medicine—treating diseases and saving lives."

"Only medicines that people can afford are good medicines, and that should be our goal."

"What's the point of a drug if no patient can afford it, or only a very small number of people can afford it?"

I wrote 6400 words tonight. I really tried my best. I hope I can maintain this level in the future.

Actually, I sometimes write less because besides work, I also need to read materials on biology and pharmaceuticals to ensure the technical aspects flow smoothly and the plot doesn't become too far-fetched. I'm not a professional either; my knowledge is limited. I need to read books to gain a deeper understanding of many things in order to write about the logic behind drug development. After all, the protagonist can't make such basic logical errors when developing a drug. Also: this book is more like Black Technology research novel. The protagonist doesn't just produce a Black Technology product and make money; he needs to decipher the theories and knowledge behind it to use for his own benefit. If he can't be self-reliant, how is this different from buying advanced technology from Europe and America? How is it different from being a technology comprador for some companies? A protagonist in Black Technology novel should have some ambition and ideals, right? With a system, why would he be a technology comprador for aliens?

End of Chapter
Prev
NovelSummaries
Next

Explore the wiki

China
Eagle Country

Comments

No comments yet.
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS